Figure 2 : Comparison of CEA, NSE, and CYFRA21-1 levels in bronchoalveolar lavage fluid between benign and malignant groups.

From: Evaluation of VEGF-C and Tumor Markers in Bronchoalveolar Lavage Fluid for Lung Cancer Diagnosis

Figure 2

The level of NSE was significantly higher in lung cancer patients than those in benign diseases (P = 0.018) (A); no significant difference of NSE (P = 0.375) (B) or CYFRA21-1 (P = 0.838) (C) levels was found between malignant and nonmalignant groups. Horizontal lines represent the mean values.